Current Month 2011
Article Features
  Aspirin May Slow Recurrence in Breast Cancer Patients
Better Classification to Improve Treatments for Breast Cancer
Biomarker in an Aggressive Breast Cancer is Identified
Cancer Leaves a Common Fingerprint on DNA
Exercise Associated with Reduced Risk of Breast Cancer in African-American Women
Leukemia Drug Shows Promise for Skin, Breast and Other Cancers
Medicaid Reimbursements May Affect Cancer Screening Rates Among Beneficiaries
New Biomarker Highly Promising for Predicting Breast Cancer Outcomes
New Research Sheds Light on How Aspirin Works to Reduce Cancer Deaths
Novel Gene Predicts Both Breast Cancer Relapse and Response to Chemotherapy
Patient Perspectives on Breast Reconstruction Following Mastectomy
Researchers Develop New Approach to Identify ‘Drivers’ of Cancer
Women With Severe, Chronic Health Issues Are Screened For Breast Cancer Less Often


Aspirin May Slow Recurrence in Breast Cancer Patients

New findings published in the journal Cancer Research reveal that some postmenopausal overweight breast cancer patients who use common anti-inflammatory drugs like aspirin or ibuprofen have significantly lower breast cancer recurrence rates.

Researchers from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio and the University of Texas at Austin began by examining blood serum from CTRC breast cancer patients, said CTRC oncologist Andrew Brenner, M.D., Ph.D.

They placed the serum in a culture of fat cells that make estrogen, and then placed the serum on breast cancer cells. The serum from overweight and obese patients caused the cancer cells to grow much more aggressively than the serum from patients who were not overweight.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon